News

DelSiTech Awarded UnitaidExplore Funding for Innovations in Paediatric Healthcare

DelSiTech Awarded UnitaidExplore Funding for Innovations in Paediatric…

ExeVir Bio BV announces its participation in the 8th Annual Healthtech Investment Forum organized by SACHS Associates taking place virtually 5th-6th October 2021.

Torsten Mummenbrauer, Chief Executive Officer of ExeVir will…

Versameb at Sachs 21st Annual Biotech in Europe Forum

Isabel Ferreira speaking on the “Platform Technologies and…

Arix Bioscience plc Interim results for the six months ended 30 June 2021

LONDON, 12 August 2021: Arix Bioscience plc (“Arix”, LSE:…

Novo Holdings posts record income and returns of DKK 29 billion (EUR 4 billion) in 2020

Novo Holdings’ 2020 result is based on a strong performance…

Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy

LONDON, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:…

Ori Biotech announces a $9.4M seed round to advance innovation in Cell and Gene Therapy manufacturing

Syndicate includes leading UK investors Amadeus Capital Partners,…

Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations

LONDON, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:…

Edinburgh Molecular Imaging Closes Financing

To accelerate development of molecular targeted systemic radiotherapy…

Forendo Pharma signs important License and Collaboration Deal with Leading Pharma Company

Forendo Pharma, a clinical stage drug development company focusing…

STORM Therapeutics’ collaborator awarded ASH–BSH Abstract Achievement Award at the 61st ASH Annual Meeting & Exposition

09 December 2019, Cambridge, UK: STORM Therapeutics, the biotechnology…

ImaginAb Initiates Phase II Clinical Trial at Penn Medicine

LOS ANGELES, Dec. 9, 2019 /PRNewswire/ -- ImaginAb Inc., a clinical-stage…

Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home

Enzyre, which is developing breakthrough ambulant diagnostic…

IXICO to Present Abstracts at Upcoming Clinical Trials on Alzheimer’s Disease Congress

IXICO plc (AIM: IXI), the AI data analytics company delivering…

Owkin Teams up with NVIDIA and King’s College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning

PARIS and NEW YORK, Dec. 2, 2019 /PRNewswire/ -- Owkin, which…

We’d love to hear from you

For more information about Optimum Strategic Communications, please get in touch.

Get in touch

© Optimum Strategic Communications.